Derivation of a simple risk calculator for predicting clinical worsening in patients with pulmonary hypertension due to interstitial lung disease
Background: Pulmonary hypertension due to interstitial lung disease (ILD-PH) portends very poor clinical outcomes, with a median survival time of 1.5 to 2 years. Currently, there is no tool to assess the risk of clinical worsening in patients with ILD-PH. Our aim was to derive a simple and practical...
Saved in:
| Main Authors: | K. El-Kersh, R. Bag, N. Bhatt, C. King, A. Waxman, F. Rischard, H. Kim, D. Cella, E. Shen, SD Nathan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | JHLT Open |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2950133425000011 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of pulmonary rehabilitation program in patients with interstitial lung disease with or without pulmonary hypertension
by: Mona Abd Elsalam Taha El Gazzar, et al.
Published: (2025-05-01) -
Physician perspectives on pulmonary hypertension in ILD: results of a cases-based survey
by: Ho Cheol Kim, et al.
Published: (2025-05-01) -
Peripheral and pulmonary telomere lengths in patients with non-idiopathic pulmonary fibrosis interstitial lung diseases
by: Yujie Shi, et al.
Published: (2025-08-01) -
Study Design and Rationale for the PHINDER Study: Pulmonary Hypertension Screening in Patients with Interstitial Lung Disease for Earlier Detection
by: Tejaswini Kulkarni, et al.
Published: (2025-07-01) -
Computed tomography in evaluating the development of different types of pulmonary fibrosis in patients with interstitial lung diseases
by: A. A. Speranskaya, et al.
Published: (2016-03-01)